Merck & Co Inc - Ends Favezelimab Clinical Development Program, Stops Enrollment in Keyform-008 Trial
默沙東公司 - 終止Favezelimab臨床開發項目,停止Keyform-008試驗的招募
Merck & Co Inc - Ends Favezelimab Clinical Development Program, Stops Enrollment in Keyform-008 Trial
默沙東公司 - 終止Favezelimab臨床開發項目,停止Keyform-008試驗的招募
使用瀏覽器的分享功能,分享給你的好友吧